Chugai To Remain Unscathed By Roche's Internal Restructuring And Cost-cutting Measures
This article was originally published in The Pink Sheet Daily
Executive Summary
Roche CEO Schwan also informed analysts that the company is not considering expanding its business into other areas such as a pharmaceutical generics or biosimilars.